Publications

Latest Publications

2023.03.28
Response to the Risk of Misconduct in Business in China(2) - Facilitating Information Sharing with Chinese Subsidiaries
2023.03.28
Legal Affairs for Chinese Life Sciences and Healthcare No.17: Enforcement of the Rules for Responsible Supervision and Management of Quality and Safety Enforcement Entities for Drugs, Cosmetics and Medical Devices
2023.03.28
[Report from China] Spring is the Season for Politics
2023.03
Legal Status of an Insurance Beneficiary under the Insurance Act: Changes to the Rule and Its Effects on Legal Interpretation
2023.03.24
High-Speed Trading Regulations in Japan – Latest Developments Almost Four Years after their Introduction –
2023.03.24
Compliance with Building Standards under the New Energy Regulations in Japan
2023.03.01
A Practical Commentary on the “Whistleblowing System” for Contact Persons at Reporting Desks - Practical Points in Operating the System and a Commentary on Cases -
2023.02.28
[Report from China] Chinese Courtroom TV Series – “Draw the Line”
2023.02.28
Response to the Risk of Misconduct in Business in China – Focusing on the Response to Signs of Misconduct
2023.02.28
Legal Affairs for Chinese Life Sciences and Healthcare No.16: Rejection of UCB Pharma S.A. and GlaxoSmithKline (Ireland) Limited in the Extraterritorial Off-Site Inspection
2023.02.28
A Commentary on the New Draft Amendment to the “Companies Law” of China – In Comparison with the First Draft Amendment
2023.02.28
Impact of the Enactment of the German Act, "Act on Corporate Due Diligence in Supply Chains," on Japanese Companies
2023.02.28
National Comparison Tables - Japan part
2023.02.27
China’s Life Science and Healthcare-No.3 Amendment of the Regulations on Cosmetics in China
2023.01.31
Attribution of the Right to Claim Mutual Aid Money Paid for an Event Covered by Mutual Aid that has Occurred after Renewal of the Contract Therefor
2023.01.31
Factoring and Insolvency Proceedings
2023.01.31
Signs of the Introduction of a Majority Vote-based Out-of-Court Liquidation Procedure – The Direction of New Legislation for Business Restructuring -
2023.01.20
[Report from China] Traveling to China Immediately after the Lifting of the “Zero-Covid” Policy
2023.01.20
Legal Affairs for Chinese Life Sciences and Healthcare No.15: System of the Person Responsible for the Production Safety (Safety Officer) of Food and Food-related Products in China
2023.01.20
Labor Issues after Reclassification of the Novel Coronavirus Infectious Disease as a “Category B Infectious Disease Managed under Category B Protocols”

Other publications

ページTOPへ